Minocycline in Acute Cerebral Hemorrhage
Author(s) -
Abdelrahman Y. Fouda,
Andrea Sikora,
Samantha Spellicy,
Jennifer L. Waller,
Wenbo Zhi,
David C. Hess,
Adviye Ergul,
David J. Edwards,
Susan C. Fagan,
Jeffrey A. Switzer
Publication year - 2017
Publication title -
stroke
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.117.018658
Subject(s) - medicine , minocycline , intracerebral hemorrhage , anesthesia , neuroprotection , stroke (engine) , dosing , pharmacokinetics , pharmacology , subarachnoid hemorrhage , antibiotics , mechanical engineering , microbiology and biotechnology , biology , engineering
Minocycline is under investigation as a neurovascular protective agent for stroke. This study evaluated the pharmacokinetic, anti-inflammatory, and safety profile of minocycline after intracerebral hemorrhage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom